ROMANO, ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 5.017
AS - Asia 2.964
EU - Europa 1.113
SA - Sud America 403
AF - Africa 399
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 13
Totale 9.942
Nazione #
US - Stati Uniti d'America 4.804
SG - Singapore 840
VN - Vietnam 764
CN - Cina 474
BR - Brasile 252
HK - Hong Kong 230
IT - Italia 210
DE - Germania 129
FI - Finlandia 102
FR - Francia 90
GB - Regno Unito 87
IN - India 87
PL - Polonia 52
TR - Turchia 51
SE - Svezia 48
BD - Bangladesh 46
JP - Giappone 41
AR - Argentina 40
CA - Canada 40
NL - Olanda 39
IQ - Iraq 36
RU - Federazione Russa 35
MX - Messico 29
PH - Filippine 29
UA - Ucraina 26
ZA - Sudafrica 25
ID - Indonesia 24
CO - Colombia 23
SA - Arabia Saudita 21
EC - Ecuador 20
IE - Irlanda 20
MA - Marocco 20
UZ - Uzbekistan 19
ES - Italia 18
ET - Etiopia 18
JO - Giordania 18
PK - Pakistan 18
TH - Thailandia 18
TW - Taiwan 18
AT - Austria 17
BJ - Benin 17
KR - Corea 17
KG - Kirghizistan 16
RO - Romania 16
CI - Costa d'Avorio 15
EG - Egitto 15
KE - Kenya 15
MN - Mongolia 15
MY - Malesia 15
AM - Armenia 14
BF - Burkina Faso 14
CV - Capo Verde 14
GH - Ghana 14
HN - Honduras 14
TZ - Tanzania 14
CZ - Repubblica Ceca 13
HR - Croazia 13
LV - Lettonia 13
RS - Serbia 13
TN - Tunisia 13
AL - Albania 12
AO - Angola 12
CL - Cile 12
GN - Guinea 12
IS - Islanda 12
LC - Santa Lucia 12
LU - Lussemburgo 12
MD - Moldavia 12
PE - Perù 12
TJ - Tagikistan 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 11
DZ - Algeria 11
GR - Grecia 11
HU - Ungheria 11
KH - Cambogia 11
LB - Libano 11
NI - Nicaragua 11
NP - Nepal 11
AZ - Azerbaigian 10
BA - Bosnia-Erzegovina 10
BB - Barbados 10
BO - Bolivia 10
BW - Botswana 10
GT - Guatemala 10
LA - Repubblica Popolare Democratica del Laos 10
SN - Senegal 10
YE - Yemen 10
BS - Bahamas 9
BZ - Belize 9
CD - Congo 9
CM - Camerun 9
LY - Libia 9
PS - Palestinian Territory 9
PY - Paraguay 9
RW - Ruanda 9
SI - Slovenia 9
ZM - Zambia 9
CH - Svizzera 8
DJ - Gibuti 8
Totale 9.584
Città #
Fairfield 609
Ashburn 604
Singapore 520
San Jose 459
Woodbridge 354
Houston 276
Chandler 261
Cambridge 234
Seattle 226
Ho Chi Minh City 223
Hong Kong 205
Ann Arbor 202
Hanoi 199
Wilmington 199
Beijing 107
Los Angeles 80
Santa Clara 69
Boardman 65
San Diego 63
Helsinki 60
New York 57
Munich 56
Princeton 48
Da Nang 44
Lauterbourg 44
Des Moines 42
Dong Ket 41
Medford 38
Jacksonville 37
Bytom 36
Chicago 33
Roxbury 33
Padova 32
Tokyo 32
Nanjing 31
Haiphong 28
São Paulo 28
Guangzhou 26
Buffalo 24
Frankfurt am Main 22
Orem 21
Dearborn 18
Milan 18
Amman 17
Cotonou 17
Dublin 17
Redondo Beach 16
Abidjan 15
Addis Ababa 15
Tashkent 15
Ulan Bator 15
Bishkek 14
Biên Hòa 14
Can Tho 14
London 14
Shenyang 14
Hefei 13
Johannesburg 13
Riga 13
Atlanta 12
Castries 12
Montreal 12
Nairobi 12
Turku 12
Accra 11
Baghdad 11
Boston 11
Chennai 11
Conakry 11
Dallas 11
Dar es Salaam 11
Falls Church 11
Hải Dương 11
Istanbul 11
Managua 11
Nanchang 11
Ouagadougou 11
Phnom Penh 11
Reykjavik 11
Riyadh 11
Shanghai 11
Bologna 10
Brooklyn 10
Bến Tre 10
Cairo 10
Dakar 10
Dushanbe 10
Paris 10
Praia 10
Stockholm 10
Tirana 10
Vientiane 10
Amsterdam 9
Bangkok 9
Kigali 9
Lima 9
Lusaka 9
Nassau 9
Poplar 9
Quito 9
Totale 6.469
Nome #
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 355
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial 324
New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: can we use an imputed value of serum creatinine? 297
Newly diagnosed Hepatocellular Carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study 297
Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis 291
Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies. 281
Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites. 265
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 264
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis: results of a randomized controlled clinical trial 258
Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study. 254
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 254
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 251
The liver: Another organ involved in Muir Torre syndrome? 242
Reply to: "A cut-off serum creatinine value of 1.5 mg/dl for AKI--to be or not to be". 235
Prognostic Evaluation of the Donor Risk Index Among a Prospective Cohort of Italian Patients Undergoing Liver Transplantation 234
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 232
Validation of the BCLC prognostic system in surgical hepatocellular cancer patients. 231
Terlipressin given by continuous i.v. infusion versus i.v. boluses in the treatment of hepatorenal syndrome: A randomized controlled study. 230
miRNA Expression and HCC Occurrence in HCV Cirrhotic Patients Treated with Direct Acting Antivirals 229
Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis 227
Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections. 225
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis 223
Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure 219
The liver: Another organ involved in Muir Torre syndrome? 218
Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis. 217
Prospective validation of a new priority allocation model for liver transplant candidates: an interim analysis. 216
Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome 212
Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure 208
Why and how to measure renal function in patients with liver disease 207
Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation. 205
Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae 205
Natural history of acute kidney disease in patients with cirrhosis 199
Assessment of bone mineral density in patients with cirrhosis treated with third-generation nucleos(t)ide analogues: comparison between tenofovir and entecavir 196
Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation 186
Progression of hepatocellular carcinoma before liver transplantation: dropout or liver transplantation? 182
Garlic extract prevents CCl4-induced liver fibrosis in rats: The role of tissue transglutaminase 182
Coffee reduces liver damage in a rat model of steatohepatitis: The underlying mechanisms and the role of polyphenols and melanoidins 180
How to improve care in outpatients with cirrhosis and ascites: A new model of care coordination by consultant hepatologists. 169
Relapse after direct-acting antivirals (DAAs) in cirrhotic patients with hepatitis C is highly related to development of liver cancer 167
Bacterial infections in cirrhosis: epidemiology and prevalence of antibiotic resistence, a restrospective monocentric study 158
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: Clinical and virological outcomes 153
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis. 144
Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae: the last therapeutic challenge. 135
Hepatocarcinoma in chronic viral hepatitis: from epidemiological data, through new pathophysiological findings, up to new possible clinical tools 125
Follow-up post-HCV virological response to DAA in advanced chronic liver disease 114
Pathophysiological Differences and Differential Diagnosis of Autoimmune and Drug-Induced Hepatitis 109
Effectiveness, Safety and Patient-Reported Outcomes of Bulevirtide Therapy in Chronic Hepatitis Delta: Real-World Evidence From a Prospective Observational Study 6
Totale 10.011
Categoria #
all - tutte 27.548
article - articoli 26.612
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.160


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202174 0 0 0 0 0 0 0 0 0 0 0 74
2021/2022717 16 87 97 41 42 35 71 77 50 11 60 130
2022/2023509 96 61 13 66 64 85 1 30 62 2 28 1
2023/2024246 10 38 31 30 21 29 20 17 3 10 20 17
2024/20251.139 3 88 56 55 117 54 39 102 70 41 199 315
2025/20265.054 227 340 572 738 481 197 1.020 405 511 301 260 2
Totale 10.011